LexaGene Holdings (OTCQB: LXXGF – CVE: LXG) CEO Dr. Jack Regan joined Steve Darling from Proactive to bring news successfully used their utilized their MiQLab System to detect the presence of Mycoplasma. This is a common microbial contaminant responsible for substantial losses in both time and money for biopharmaceutical manufacturers.
Regan telling Proactive, this is a major advancement for biopharmaceuticals manufacturers with the system able to provide a time benefit that is 336-times faster than conventional methods.